Valuation: Optiscan Imaging Limited

Market Cap 125M 87.68M 76.21M 71.15M 65.31M 123M 8.36B 839M 329M 4.17B 329M 322M 13.75B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 85.54M 74.34M 69.4M 63.71M 120M 8.15B 818M 321M 4.07B 321M 314M 13.41B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 day+6.90%
1 week+3.33%
Current month+6.90%
1 month+14.81%
3 months+37.78%
6 months+72.22%
Current year+55.00%
1 week 0.14
Extreme 0.145
0.16
1 month 0.13
Extreme 0.13
0.16
Current year 0.08
Extreme 0.08
0.16
1 year 0.08
Extreme 0.079
0.16
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2021-02-09
Chairman - 2021-04-18
Director/Board Member - 2021-05-05
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Free

Director

230,502 0.0221%
1/15/26 Free

Chairman

419,094 0.0401%
1/15/26 Free

Chief Executive Officer

6,157,719 0.5897%
Change 5-day change 1-year change 3-year change Capi.($)
+6.90%+3.33%+63.16%+101.30% 106M
+0.81%+5.43%-12.65%-14.75% 14.13B
-1.55%-9.17%+36.41%-9.25% 3.84B
+1.38%+9.50%-35.47%-53.47% 1.29B
+6.00%+12.97%-32.01%-39.29% 1.25B
+0.77%-3.70%+38.37%+89.96% 1.17B
+0.80%+3.84%-44.99% - 960M
-9.05%-10.16%+17.46%+87.43% 455M
+8.97%+8.47%+83.38% - 358M
-0.26%+4.37%-60.44%+234.49% 262M
Average +1.48%+2.45%+5.32%+49.55% 2.38B
Weighted average by Cap. +0.68%+3.47%-3.96%-6.43%

Financials

2024 2025
Net sales 2.99M 2.09M 1.82M 1.7M 1.56M 2.93M 199M 19.99M 7.83M 99.32M 7.85M 7.68M 328M 3.72M 2.61M 2.27M 2.11M 1.94M 3.66M 248M 24.93M 9.77M 124M 9.79M 9.57M 409M
Net income -6.06M -4.24M -3.69M -3.44M -3.16M -5.96M -404M -40.58M -15.89M -202M -15.93M -15.58M -665M -6.31M -4.42M -3.84M -3.58M -3.29M -6.2M -421M -42.26M -16.55M -210M -16.59M -16.22M -692M
Net Debt -11.01M -7.71M -6.7M -6.25M -5.74M -10.82M -734M -73.72M -28.87M -366M -28.94M -28.3M -1.21B -3.07M -2.15M -1.87M -1.74M -1.6M -3.02M -205M -20.56M -8.05M -102M -8.07M -7.89M -337M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-08-04 A$0.1550 +6.90% 165,069
26-08-03 A$0.1450 0.00% 252,423
26-07-31 A$0.1450 -3.33% 172,716
26-07-30 A$0.1500 0.00% 23,762
26-07-29 A$0.1500 0.00% 95